title: [Case of acne fulminans associated with hemophagocytosis].
authors.affiliation: Department of Hematology, Nephrology and Rheumatology, Kinki University School of Medicine, Osakasayama.
authors.forename: Chise
authors.initials: C
authors.lastname: Tamaki
authors.forename: Junichi
authors.initials: J
authors.lastname: Miyatake
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Yamagata
authors.forename: Yuji
authors.initials: Y
authors.lastname: Nozaki
authors.forename: Heiseki
authors.initials: H
authors.lastname: Yu
authors.forename: Masafumi
authors.initials: M
authors.lastname: Sugiyama
authors.forename: Shinya
authors.initials: S
authors.lastname: Ikoma
authors.forename: Koji
authors.initials: K
authors.lastname: Kinoshita
authors.forename: Masanori
authors.initials: M
authors.lastname: Funauchi
authors.forename: Akihisa
authors.initials: A
authors.lastname: Kanamaru
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy / Q000209:etiology*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018771:Arthralgia / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015616:Histiocytosis, Non-Langerhans-Cell / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012460:Sulfasalazine / Q000008:administration & dosage; D013585:Synovitis / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine; D011239:Prednisolone; D008775:Methylprednisolone